Investment
Features
FeesSafety
Academy
More
Pluang+

Compare iShares MSCI France ETF (EWQ) vs Twist Bioscience Corp (TWST) Price & Performance

iShares MSCI France ETFTrade
Twist Bioscience CorpTrade

Price performance (Past 24H)

Key statistics

iShares MSCI France ETF vs Twist Bioscience Corp — how do they compare? iShares MSCI France ETF trades at $47.54, while Twist Bioscience Corp trades at $123.34 (market cap $7.72B). The key difference: Twist Bioscience Corp is trading nearer its 52-week high, iShares MSCI France ETF nearer its low. Which is the better fit depends on your goals.

EWQTWST
Sector
Broad Market / FactorHealth
52-Week High
$48.35$124.88
52-Week Low
$41.68$24.16
Market Cap
$7.72B
Enterprise Value
$7.65B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

iShares MSCI France ETF

EWQ, the iShares MSCI France ETF, trades at $47.54, down 0.44% on the day, with a bullish technical signal from moving averages but overbought RSI readings. The ETF is concentrated in industrials and benefits from positive momentum in European equities, with a dividend scheduled for June 2026. Recent news highlights France's tech investments and ECB rate decisions influencing regional economic sentiment.

The outlook for EWQ is supported by favorable European market trends and institutional interest, though risks include geopolitical tensions affecting energy prices and potential ECB tightening. Investors should weigh the ETF's exposure to French equities against macroeconomic headwinds for balanced positioning.

Twist Bioscience Corp

Twist Bioscience (TWST) trades at $123.76, down 0.9% on the day, with a bullish technical signal from moving averages but bearish oscillators. Revenue growth is strong, with 2025 revenue at $376.57 million, though the company remains unprofitable with a net income margin of -31.66%. Recent news highlights an upsized $300 million public offering and an analyst upgrade, contributing to positive sentiment.

The outlook is mixed: robust revenue growth and high analyst buy ratings (78.57%) support upside potential, but persistent losses, negative cash flow, and high valuation ratios pose significant risks. Investors should weigh the growth trajectory against the path to profitability and cash burn concerns.

Returns comparison

Trailing returns across standard periods

About iShares MSCI France ETF

EWQ is a country-specific ETF that tracks the performance of the French equity market. It provides exposure to major global brands across sectors like luxury goods, industrials, and healthcare, including LVMH, Schneider Electric, and Hermes.

Read more on EWQ

About Twist Bioscience Corp

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.

Read more on TWST